Selected research
Industry Research
Genome Sequencing Service Industry Research Report 2026
Market perspective
The global Genome Sequencing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Genome Sequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Genome Sequencing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Genome Sequencing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Genome Sequencing Service include Illumina, Thermo Fisher Scientific, BGI Genomics, Agilent Technologies, CD Genomics, Azenta Life Sciences, Broad Clinical Labs, Macrogen and GE Healthcare Life Sciences, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Genome Sequencing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Genome Sequencing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Genome Sequencing Service Market by Company
Illumina
Thermo Fisher Scientific
BGI Genomics
Agilent Technologies
CD Genomics
Azenta Life Sciences
Broad Clinical Labs
Macrogen
GE Healthcare Life Sciences
Johnson & Johnson
Abbott Laboratories
Bayer
Microchip Biotechnologies
GeneDx
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Novogene
Eurofins Genomics
Psomagen
Genome Sequencing Service Segment by Type
Whole-Genome Sequencing
Whole exome Sequencing
Others
Genome Sequencing Service Segment by Application
Humanity
Plant
Animal
Microorganism
Virus
Genome Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genome Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Genome Sequencing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Whole-Genome Sequencing
- Whole exome Sequencing
- Others
Applications
- Humanity
- Plant
- Animal
- Microorganism
- Virus
Companies covered
- Illumina
- Thermo Fisher Scientific
- BGI Genomics
- Agilent Technologies
- CD Genomics
- Azenta Life Sciences
- Broad Clinical Labs
- Macrogen
- GE Healthcare Life Sciences
- Johnson & Johnson
- Abbott Laboratories
- Bayer
- Microchip Biotechnologies
- GeneDx
- Commonwealth Biotechnologies
- ZS Genetics
- Pacific Biosciences
- Novogene
- Eurofins Genomics
- Psomagen
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Genome Sequencing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Whole-Genome Sequencing
- 2.2.3 Whole exome Sequencing
- 2.2.4 Others
- 2.3 Genome Sequencing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Humanity
- 2.3.3 Plant
- 2.3.4 Animal
- 2.3.5 Microorganism
- 2.3.6 Virus
- 2.4 Assumptions and Limitations
3 Genome Sequencing Service Breakdown Data by Type
- 3.1 Global Genome Sequencing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Genome Sequencing Service Forecasted Market Size by Type (2027-2032)
4 Genome Sequencing Service Breakdown Data by Application
- 4.1 Global Genome Sequencing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Genome Sequencing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Genome Sequencing Service Market Perspective (2021-2032)
- 5.2 Global Genome Sequencing Service Growth Trends by Region
- 5.2.1 Global Genome Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Genome Sequencing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Genome Sequencing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Genome Sequencing Service Market Dynamics
- 5.3.1 Genome Sequencing Service Industry Trends
- 5.3.2 Genome Sequencing Service Market Drivers
- 5.3.3 Genome Sequencing Service Market Challenges
- 5.3.4 Genome Sequencing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Genome Sequencing Service Players by Revenue
- 6.1.1 Global Top Genome Sequencing Service Players by Revenue (2021-2026)
- 6.1.2 Global Genome Sequencing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Genome Sequencing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Genome Sequencing Service Head Office and Area Served
- 6.4 Global Genome Sequencing Service Players, Product Type & Application
- 6.5 Global Genome Sequencing Service Manufacturers Established Date
- 6.6 Global Genome Sequencing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Genome Sequencing Service Market Size (2021-2032)
- 7.2 North America Genome Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Genome Sequencing Service Market Size by Country (2021-2026)
- 7.4 North America Genome Sequencing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Genome Sequencing Service Market Size (2021-2032)
- 8.2 Europe Genome Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Genome Sequencing Service Market Size by Country (2021-2026)
- 8.4 Europe Genome Sequencing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Genome Sequencing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Genome Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Genome Sequencing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Genome Sequencing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Genome Sequencing Service Market Size (2021-2032)
- 10.2 South America Genome Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Genome Sequencing Service Market Size by Country (2021-2026)
- 10.4 South America Genome Sequencing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Genome Sequencing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Genome Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Genome Sequencing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Genome Sequencing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Illumina
- 12.1.1 Illumina Company Information
- 12.1.2 Illumina Business Overview
- 12.1.3 Illumina Revenue in Genome Sequencing Service Business (2021-2026)
- 12.1.4 Illumina Genome Sequencing Service Product Portfolio
- 12.1.5 Illumina Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in Genome Sequencing Service Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific Genome Sequencing Service Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 BGI Genomics
- 12.3.1 BGI Genomics Company Information
- 12.3.2 BGI Genomics Business Overview
- 12.3.3 BGI Genomics Revenue in Genome Sequencing Service Business (2021-2026)
- 12.3.4 BGI Genomics Genome Sequencing Service Product Portfolio
- 12.3.5 BGI Genomics Recent Developments
- 12.4 Agilent Technologies
- 12.4.1 Agilent Technologies Company Information
- 12.4.2 Agilent Technologies Business Overview
- 12.4.3 Agilent Technologies Revenue in Genome Sequencing Service Business (2021-2026)
- 12.4.4 Agilent Technologies Genome Sequencing Service Product Portfolio
- 12.4.5 Agilent Technologies Recent Developments
- 12.5 CD Genomics
- 12.5.1 CD Genomics Company Information
- 12.5.2 CD Genomics Business Overview
- 12.5.3 CD Genomics Revenue in Genome Sequencing Service Business (2021-2026)
- 12.5.4 CD Genomics Genome Sequencing Service Product Portfolio
- 12.5.5 CD Genomics Recent Developments
- 12.6 Azenta Life Sciences
- 12.6.1 Azenta Life Sciences Company Information
- 12.6.2 Azenta Life Sciences Business Overview
- 12.6.3 Azenta Life Sciences Revenue in Genome Sequencing Service Business (2021-2026)
- 12.6.4 Azenta Life Sciences Genome Sequencing Service Product Portfolio
- 12.6.5 Azenta Life Sciences Recent Developments
- 12.7 Broad Clinical Labs
- 12.7.1 Broad Clinical Labs Company Information
- 12.7.2 Broad Clinical Labs Business Overview
- 12.7.3 Broad Clinical Labs Revenue in Genome Sequencing Service Business (2021-2026)
- 12.7.4 Broad Clinical Labs Genome Sequencing Service Product Portfolio
- 12.7.5 Broad Clinical Labs Recent Developments
- 12.8 Macrogen
- 12.8.1 Macrogen Company Information
- 12.8.2 Macrogen Business Overview
- 12.8.3 Macrogen Revenue in Genome Sequencing Service Business (2021-2026)
- 12.8.4 Macrogen Genome Sequencing Service Product Portfolio
- 12.8.5 Macrogen Recent Developments
- 12.9 GE Healthcare Life Sciences
- 12.9.1 GE Healthcare Life Sciences Company Information
- 12.9.2 GE Healthcare Life Sciences Business Overview
- 12.9.3 GE Healthcare Life Sciences Revenue in Genome Sequencing Service Business (2021-2026)
- 12.9.4 GE Healthcare Life Sciences Genome Sequencing Service Product Portfolio
- 12.9.5 GE Healthcare Life Sciences Recent Developments
- 12.10 Johnson & Johnson
- 12.10.1 Johnson & Johnson Company Information
- 12.10.2 Johnson & Johnson Business Overview
- 12.10.3 Johnson & Johnson Revenue in Genome Sequencing Service Business (2021-2026)
- 12.10.4 Johnson & Johnson Genome Sequencing Service Product Portfolio
- 12.10.5 Johnson & Johnson Recent Developments
- 12.11 Abbott Laboratories
- 12.11.1 Abbott Laboratories Company Information
- 12.11.2 Abbott Laboratories Business Overview
- 12.11.3 Abbott Laboratories Revenue in Genome Sequencing Service Business (2021-2026)
- 12.11.4 Abbott Laboratories Genome Sequencing Service Product Portfolio
- 12.11.5 Abbott Laboratories Recent Developments
- 12.12 Bayer
- 12.12.1 Bayer Company Information
- 12.12.2 Bayer Business Overview
- 12.12.3 Bayer Revenue in Genome Sequencing Service Business (2021-2026)
- 12.12.4 Bayer Genome Sequencing Service Product Portfolio
- 12.12.5 Bayer Recent Developments
- 12.13 Microchip Biotechnologies
- 12.13.1 Microchip Biotechnologies Company Information
- 12.13.2 Microchip Biotechnologies Business Overview
- 12.13.3 Microchip Biotechnologies Revenue in Genome Sequencing Service Business (2021-2026)
- 12.13.4 Microchip Biotechnologies Genome Sequencing Service Product Portfolio
- 12.13.5 Microchip Biotechnologies Recent Developments
- 12.14 GeneDx
- 12.14.1 GeneDx Company Information
- 12.14.2 GeneDx Business Overview
- 12.14.3 GeneDx Revenue in Genome Sequencing Service Business (2021-2026)
- 12.14.4 GeneDx Genome Sequencing Service Product Portfolio
- 12.14.5 GeneDx Recent Developments
- 12.15 Commonwealth Biotechnologies
- 12.15.1 Commonwealth Biotechnologies Company Information
- 12.15.2 Commonwealth Biotechnologies Business Overview
- 12.15.3 Commonwealth Biotechnologies Revenue in Genome Sequencing Service Business (2021-2026)
- 12.15.4 Commonwealth Biotechnologies Genome Sequencing Service Product Portfolio
- 12.15.5 Commonwealth Biotechnologies Recent Developments
- 12.16 ZS Genetics
- 12.16.1 ZS Genetics Company Information
- 12.16.2 ZS Genetics Business Overview
- 12.16.3 ZS Genetics Revenue in Genome Sequencing Service Business (2021-2026)
- 12.16.4 ZS Genetics Genome Sequencing Service Product Portfolio
- 12.16.5 ZS Genetics Recent Developments
- 12.17 Pacific Biosciences
- 12.17.1 Pacific Biosciences Company Information
- 12.17.2 Pacific Biosciences Business Overview
- 12.17.3 Pacific Biosciences Revenue in Genome Sequencing Service Business (2021-2026)
- 12.17.4 Pacific Biosciences Genome Sequencing Service Product Portfolio
- 12.17.5 Pacific Biosciences Recent Developments
- 12.18 Novogene
- 12.18.1 Novogene Company Information
- 12.18.2 Novogene Business Overview
- 12.18.3 Novogene Revenue in Genome Sequencing Service Business (2021-2026)
- 12.18.4 Novogene Genome Sequencing Service Product Portfolio
- 12.18.5 Novogene Recent Developments
- 12.19 Eurofins Genomics
- 12.19.1 Eurofins Genomics Company Information
- 12.19.2 Eurofins Genomics Business Overview
- 12.19.3 Eurofins Genomics Revenue in Genome Sequencing Service Business (2021-2026)
- 12.19.4 Eurofins Genomics Genome Sequencing Service Product Portfolio
- 12.19.5 Eurofins Genomics Recent Developments
- 12.20 Psomagen
- 12.20.1 Psomagen Company Information
- 12.20.2 Psomagen Business Overview
- 12.20.3 Psomagen Revenue in Genome Sequencing Service Business (2021-2026)
- 12.20.4 Psomagen Genome Sequencing Service Product Portfolio
- 12.20.5 Psomagen Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst